In 2023, Novo Nordisk A/S reported a total of 3,831,000 ton CO₂e, and a net revenue of 33,724 M USD, resulting in a emissions intensity of 114 t CO₂e / M USD.
Base year:
2018
Target year:
2030
Reduction:
1
Classification:
1.5°C
Danish multinational pharmaceutical company Novo Nordisk A S commits to reduce scope 1 and 2 emissions 100% by 2030 from a 2018 base-year.
Source: Science Based Target initative
Emissions, Revenue & Intensity
Emissions, Target & Trend
Emissions Overview | 2021 | 2022 | 2023 |
Total Emissions - Market Based (t CO₂e) | 93,000 | 2,510,000 | 3,831,000 |
---|---|---|---|
Emissions Intensity (t CO₂e / M USD) | 4 | 100 | 114 |
Cradle-to-gate Intensity (t CO₂e / M USD) | 4 | 99 | 112 |